ABBOTT SHAREHOLDERS DEFEAT DISCLOSURE PROPOSAL

For the second year in a row, Abbott Laboratories' shareholders April 28 resoundingly defeated shareholder proposals that would have forced the drug and device maker to disclose more information about political donations, divide the chief executive and chairman roles and tie executive pay to a performance standard.
The Chicago Tribune